Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

RUBIUS THERAPEUTICS, INC.

(RUBY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about RUBIUS THERAPEUTICS, INC.
10/19RUBIUS THERAPEUTICS : Morgan Stanley Adjusts Rubius Therapeutics' Price Target to $22 from..
MT
10/04RUBIUS THERAPEUTICS : Announces Preclinical Data for RTX-224, a Broad Immune Costimulatory..
AQ
10/01RUBIUS THERAPEUTICS : Announces Preclinical Data for RTX-224, a Broad Immune Costimulatory..
GL
10/01Rubius Therapeutics Announces Preclinical Data for RTX-224, a Broad Immune Costimulator..
CI
09/01Rubius Therapeutics to Participate in the Morgan Stanley 19th Annual Global Healthcare ..
GL
08/30Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer
GL
08/30Rubius Therapeutics Appoints Jim Jogerst as Chief Business Officer
CI
08/10RUBIUS THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Business ..
AQ
08/09RUBIUS THERAPEUTICS' : Q2 Net Loss Widens
MT
08/09Rubius Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30..
CI
08/09RUBIUS THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Business ..
AQ
07/30Rubius Therapeutics Appoints Dannielle Appelhans as Chief Operating Officer
CI
07/29RUBIUS THERAPEUTICS : Appoints Dannielle Appelhans as Chief Operating Officer (Form 8-K)
PU
07/29RUBIUS THERAPEUTICS : Appoints Dannielle Appelhans as Chief Operating Officer
AQ
07/29Rubius Therapeutics Appoints Dannielle Appelhans as Chief Operating Officer, Effective ..
CI
07/29Rubius Therapeutics Taps Dannielle Appelhans as Chief Operating Officer
DJ
07/22RUBIUS THERAPEUTICS : to Announce Second Quarter 2021 Financial Results
AQ
07/15RUBIUS THERAPEUTICS : Announces Publication of RTX-240 Preclinical Data in Cancer Immunolo..
AQ
07/15Rubius Therapeutics Announces Publication of RTX-240 Preclinical Data in Cancer Immunol..
CI
06/28Rubius Therapeutics, Inc. Enters into a Second Amendment to That Certain Loan and Secur..
CI
06/25RUBIUS THERAPEUTICS, INC.(NASDAQGS : RUBY) dropped from Russell 3000E Value Index
CI
06/25RUBIUS THERAPEUTICS, INC.(NASDAQGS : RUBY) dropped from Russell Small Cap Comp Value Index
CI
06/25RUBIUS THERAPEUTICS, INC.(NASDAQGS : RUBY) dropped from Russell 3000 Value Index
CI
06/25RUBIUS THERAPEUTICS, INC.(NASDAQGS : RUBY) dropped from Russell 2500 Value Index
CI
06/25RUBIUS THERAPEUTICS, INC.(NASDAQGS : RUBY) dropped from Russell 2000 Value Index
CI
06/24SECTOR UPDATE : Health Care Stocks Higher Late in Thursday Afternoon Session
MT
06/24SECTOR UPDATE : Health Care Stocks Slip From Highs as Less Defensive Sectors Gain Favor
MT
06/24RUBIUS THERAPEUTICS : Announces First Patient Dosed with RTX-240 in Combination with KEYTR..
AQ
06/23RUBIUS THERAPEUTICS : First Patient Dosed in Rubius Therapeutics' Trial For Advanced Solid..
MT
06/23Rubius Therapeutics Announces First Patient Dosed with RTX-240 in Combination with KEYT..
GL
06/23Rubius Therapeutics, Inc. Announces First Patient Dosed with RTX-240 in Combination wit..
CI
06/21RUBIUS THERAPEUTICS, INC.(NASDAQGS : RUBY) added to S&P Biotechnology Select Industry Inde..
CI
06/15Certain Restricted Stock Units of Rubius Therapeutics, Inc. are subject to a Lock-Up Ag..
CI
06/15Certain Common Stock of Rubius Therapeutics, Inc. are subject to a Lock-Up Agreement En..
CI
06/15Certain Stock Options of Rubius Therapeutics, Inc. are subject to a Lock-Up Agreement E..
CI
05/20Rubius Therapeutics to Participate in Jefferies Virtual Healthcare Conference
GL
05/19Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial ..
GL
05/19Rubius Therapeutics to Present Trials in Progress Poster on the Phase 1 Clinical Trial ..
CI
05/18RUBIUS THERAPEUTICS : Morgan Stanley Adjusts Rubius Therapeutics' Price Target to $25 from..
MT
05/12RUBIUS THERAPEUTICS : Announces Publication of RTX-321 Preclinical Data in Nature Communic..
AQ
05/12Rubius Therapeutics Announces Publication of RTX-321 Preclinical Data in Nature Communi..
CI
05/12RUBIUS THERAPEUTICS : Continued Progress in Advancing Clinical Programs with Further Enrol..
PU
05/10RUBIUS THERAPEUTICS : Posts Narrower Q1 Loss
MT
05/10Rubius Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31..
CI
05/10RUBIUS THERAPEUTICS : Reports First Quarter 2021 Financial Results and Provides Business U..
AQ
04/26Rubius Therapeutics to Announce First Quarter 2021 Financial Results
GL
04/12RUBIUS THERAPEUTICS : Begins Phase 1 Clinical Trial of RTX-321 to Treat HPV 16-Positive Ca..
MT
04/12Rubius Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial of RTX-321 ..
GL
04/12Rubius Therapeutics, Inc. Announces First Patient to Dose in Phase 1 Clinical Trial of ..
CI
04/09Rubius Therapeutics Presents Initial Clinical Results from the Ongoing Phase 1/2 Clinic..
GL
03/24RUBIUS THERAPEUTICS : RUBY) sees Significant Insider buy Reversing Trend of Selling over L..
MT
03/23INSIDER TRENDS : Rubius Therapeutics Insider 90-Day Buying Trend Prolonged with Purchase
MT
03/17UPDATE : Rubius Therapeutics Plunges 24% After Pricing Upsized Offering at $29 a Share
MT
03/17RUBIUS THERAPEUTICS : Prices Upsized Offering at $29 Per Share
MT
03/16Rubius Therapeutics Prices Upsized Public Offering of Common Stock
GL
03/16RUBIUS THERAPEUTICS : Prices Upsized Public Offering of Common Stock
AQ
03/16SECTOR UPDATE : Health Care Stocks Drifting Lower in Late Trade
MT
03/16SECTOR UPDATE : Health Care Stocks Slipping But Biotechs Keeping Sector Within Range of Br..
MT
03/15US Stocks Set New Records Ahead of Fed Meeting
MT
03/15CLOSE UPDATE : US Stocks Set New Records Ahead of Fed Meeting
MT
03/15RUBIUS THERAPEUTICS : Launches Public Offering of $150 Million Shares
MT
03/15Rubius Therapeutics Announces Proposed Public Offering of Common Stock
GL
03/15SECTOR UPDATE : Health Care Stocks, Propelled by Biotech Companies, Ending on Positive Gro..
MT
03/15US Stocks Search for Direction Ahead of Federal Reserve Meeting
MT
03/15SECTOR UPDATE : Health Care Stocks Swinging Between Small Gains, Losses
MT
03/15US Stocks Search for Direction Ahead of Federal Reserve's Policy Meeting
MT
03/15RUBIUS THERAPEUTICS' : Efficacy, Safety Study Supports Potential of Cancer Treatment Candi..
MT
03/15Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-2..
GL
03/15Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-2..
CI
03/12RUBIUS THERAPEUTICS : Plans to Release RTX-240 Trial Data in Solid Tumors March 15
MT
03/12Rubius Therapeutics Announces Webcast to Review Initial Clinical Data from Ongoing Phas..
GL
03/10Rubius Therapeutics to Present Initial Clinical Results from the Ongoing Phase 1/2 Clin..
GL
03/10Rubius Therapeutics Announces Clinical Results from the Ongoing Phase 1/2 Clinical Tria..
CI
02/23RUBIUS THERAPEUTICS : Q4 Loss Narrows, Operating Expenses Decline
MT
02/23RUBIUS THERAPEUTICS : Reports Fourth Quarter and Full Year 2020 Financial Results and Prov..
AQ
1  2  3  4Next
Upcoming event on RUBIUS THERAPEUTICS, INC.
11/12/21